search icon
      blog search icon

      Applied UV, Inc. (AUVI) stock is down in aftermarket – What’s up? - Stocks Telegraph

      By Mahrukh Rehan

      Published on

      November 29, 2021

      7:00 AM UTC

      Applied UV, Inc. (AUVI) stock is down in aftermarket – What’s up? - Stocks Telegraph

      Applied UV, Inc. (AUVI) saw a decline of 6.86% in the aftermarket. However, the last trading session closed at $5.1 with an incline of 2%.

      Monthly Preferred Stock Dividend

      On 23rd November 2021, AUVI announced that the holders of the 10.5% Series A Cumulative Perpetual Preferred Stock will get a cash dividend equal to $0.21875 per share.

      Third Quarter 2021 results by AUVI

      AUVI announced third-quarter results on 16th November 2021. The company reported that the net sales climbed by 127.6% to $3,551,564. Moreover, AUVI suffered delays in completing orders in the second quarter as a result of ongoing logistical and transportation problems in numerous countries. However, the net loss was $1,080,805, compared to $890,559 in the third quarter of 2020. The rise in SG&A expenditures to enhance future operations and develop the disinfection section of the Company’s business was principally responsible for the net loss in 2021. Not only this, but the Company’s net loss during the third quarter of 2021 decreased by more than 49%. Lastly, the Company has about $11.7 million in cash on its balance sheet.

      What’s Next?

      AUVI produced large profits in the third quarter despite persistent global supply chain issues. The employees have done an outstanding job of negotiating supply chain constraints in order to get items to the clients. Moreover, sales increased by over 127 percent in Q3 and 63 percent in the first nine months of 2021. This owed to ongoing high demand for the SteriLumen product line and a steady rebound in the hotel industry for the MunnWorks subsidiary.

      Furthermore, the company is well-positioned to end the year on a good note, as sales are expected to continue to increase. AUVI is also glad to inform you that the net loss for the third quarter was significantly lower than the second quarter. Hence, the company concluded that AUVI is making progress toward profitable growth.

      AUVI’s Systems – What are the updates?

      AUVI reported on 5th November 2021 that its SteriLumen LumicideTM Ribbon kills the growing multi-drug resistant fungus, Candida Auris. SteriLumen LumicideTM Ribbon employs UVC LEDs in numerous patented designs for infection prevention in and around high-traffic locations, such as sinks and bathrooms. Lastly, C.auris can cause serious infections and spread readily amongst hospitalized patients and nursing care residents.

      So what?

      Candida Auris is a new fungus that poses a severe danger to global health. It infects the circulation, central nervous system, and various internal organs after entering the body through the skin. Multiple medication resistance has been established, and the condition is more dangerous in people with weaker immune systems. Last but not least, Candidiasis is presently regarded by the Centers for Disease Control and Prevention as one of the world’s most serious infectious illnesses.

      More From Stocks telegraph